FIGURE 3.
Multivariate Cox proportional hazards regression analysis of factors affecting time on afatinib treatment in all patients (n = 324) with advanced NSCLC harboring EGFR mutations
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.